Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Palisade Bio Inc.

    NASDAQ: PALI · Real-Time Price · USD
    0.72
    0.00 (0.35%)
    At close: Jun 05, 2025, 3:59 PM
    0.68
    -5.13%
    Pre-market: Jun 06, 2025, 08:00 AM EDT

    Palisade Bio Statistics

    Share Statistics

    Palisade Bio has 4.8M shares outstanding. The number of shares has increased by 369.53% in one year.

    Shares Outstanding

    n/a
    		 4.8M

    Shares Change (YoY)

    n/a
    		 369.53%

    Shares Change (QoQ)

    n/a
    		 58.95%

    Owned by Institutions (%)

    n/a
    		 17.25%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 392,181

    FTD / Avg. Volume

    n/a
    		 101.55%

    Short Selling Information

    The latest short interest is 175.09K, so 3.5% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 175.09K

    Short % of Shares Out

    n/a
    		 3.5%

    Short % of Float

    n/a
    		 3.67%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.66 and the forward PE ratio is -0.74. Palisade Bio's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -0.66

    Forward PE

    n/a
    		 -0.74

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.28

    P/FCF Ratio

    n/a
    		 -0.79

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Palisade Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 3.24

    Quick Ratio

    n/a
    		 3.24

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,804,750

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -84.65% in the last 52 weeks. The beta is 1.34, so Palisade Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.34

    52-Week Price Change

    n/a
    		 -84.65%

    50-Day Moving Average

    n/a
    		 0.73

    200-Day Moving Average

    n/a
    		 1.91

    Relative Strength Index (RSI)

    n/a
    		 41.94

    Average Volume (20 Days)

    n/a
    		 386,212

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -14.86M

    Net Income

    n/a
    		 -14.44M

    EBITDA

    n/a
    		 -14.86M

    EBIT

    n/a
    		 -14.45M

    Earnings Per Share (EPS)

    n/a
    		 -2.48
    Full Income Statement

    Balance Sheet

    The company has 9.82M in cash and 169K in debt, giving a net cash position of 9.65M.

    Cash & Cash Equivalents

    n/a
    		 9.82M

    Total Debt

    n/a
    		 169K

    Net Cash

    n/a
    		 9.65M

    Retained Earnings

    n/a
    		 -135.94M

    Total Assets

    n/a
    		 8.19M

    Working Capital

    n/a
    		 5.11M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.19M and capital expenditures 0, giving a free cash flow of -12.19M.

    Operating Cash Flow

    n/a
    		 -12.19M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.19M

    FCF Per Share

    n/a
    		 -2.1
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PALI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PALI is $12, which is 1566.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 1566.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 8, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Apr 8, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -27.5

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist